EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology

Melanie Jensen, Pranoy Das, Oliver Wroe-Wright, Oscar MacCormac, Francesco Marchi, Ali Elhag, Yasir A Chowdhury, Ross Laxton, Rebecca Ellmers, Omar Al-Salihi, Keyoumars Ashkan, Ranjeev Bhangoo und 4 weitere

Pathology & Oncology Research · 04.05.2026 · 32

DOI: 10.3389/pore.2026.1612388 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology & Oncology Research, online erschienen am 04.05.2026. Verfasst von Melanie Jensen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuropathology, King's College Hospital NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Astrocytoma, Biomarkers, Tumor, Brain Neoplasms, Granular Cell Tumor. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Granular cell astrocytoma (GCA) is a rare, morphologically distinct variant of IDH-wildtype glioblastoma that can appear deceptively low-grade yet behave aggressively. Its molecular features remain poorly defined, and no methylation-based classification has previously been reported.

Methods

Two GCAs diagnosed in our clinical neuropathology department were described with the integration of clinical, intraoperative, histopathological, and molecular data, including DNA methylation profiling, a targeted next-generation sequencing panel, and, in one case, whole genome sequencing (WGS).

Results

The patients were aged 63 and 54 years old, respectively, both presenting with supratentorial tumors showing granular cell morphology. Case 1 showed a densely cellular tumor composed entirely of bland-appearing granular cells without a conventional astrocytic component. Case 2 showed low-grade granular cell areas transitioning into high-grade astrocytic regions with mitoses, microvascular proliferation, and necrosis. Despite these morphological differences, both cases matched the methylation class “Glioblastoma, IDH-wildtype, mesenchymal subtype” and shared molecular features typical of glioblastoma, including chromosome +7/−10 and CDKN2A/B deletion. Both patients harbored oncogenic NF1 variants. WGS in Case 2 also revealed homozygous MTAP loss and chromoanasynthesis on chromosome 9. Case 1 received Stupp protocol chemoradiotherapy, recurred after 3 months of treatment, and died 11 months after diagnosis. Case 2 has progressed with a new posterior fossa lesion while on adjuvant temozolomide.

Conclusion

These cases demonstrate that GCAs span a morphological spectrum yet molecularly correspond to the mesenchymal subtype of IDH-wildtype glioblastoma. Integrated molecular testing is therefore essential for accurate diagnosis and for guiding clinical management, including consideration for potential clinical trial enrollment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaBiomarkers, TumorBrain NeoplasmsGranular Cell TumorHumansMiddle AgedMaleDNA MethylationFemalePrognosis

Stichwörter der Autor:innen

5-ALADNA methylation profilingIDH-wildtypeaggressive behaviourgranular cell astrocytoma/glioblastoma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Neuropathology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Neurosurgical Department, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Department of Neurosurgery, Neurocenter of Southern Switzerland, Lugano, Switzerland.
  • Molecular Neuropathology, Synnovis at King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Department of Neuro-Oncology, Guy's Cancer Centre, London, United Kingdom.

Zitieren

APA

Jensen, M., Das, P., Wroe-Wright, O., MacCormac, O., Marchi, F., Elhag, A., Chowdhury, Y. A., Laxton, R., Ellmers, R., Al-Salihi, O., Ashkan, K., Bhangoo, R., Vergani, F., Bodi, I., Reisz, Z., & Lavrador, J. P. (2026). Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology. Pathology & Oncology Research, 32. https://doi.org/10.3389/pore.2026.1612388

Vancouver

Jensen M, Das P, Wroe-Wright O, MacCormac O, Marchi F, Elhag A, et al. Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology. Pathology & Oncology Research. 2026;32. doi:10.3389/pore.2026.1612388

BibTeX
@article{Jensen2026,
  author = {Jensen, Melanie and Das, Pranoy and Wroe-Wright, Oliver and MacCormac, Oscar and Marchi, Francesco and Elhag, Ali and Chowdhury, Yasir A and Laxton, Ross and Ellmers, Rebecca and Al-Salihi, Omar and Ashkan, Keyoumars and Bhangoo, Ranjeev and Vergani, Francesco and Bodi, Istvan and Reisz, Zita and Lavrador, Jose Pedro},
  title = {Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology},
  journal = {Pathology & Oncology Research},
  year = {2026},
  volume = {32},
  doi = {10.3389/pore.2026.1612388}
}
Kostenlos starten →